Yutaro Sasaki Selected Research

Yutaro Sasaki Research Topics

Disease

8	Neoplasms (Cancer) 06/2023 - 01/2005
6	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2005
6	Carcinoma (Carcinomatosis) 01/2022 - 02/2016
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 01/2019
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 09/2018
4	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 04/2021
2	Muscular Atrophy (Muscle Atrophy) 04/2023 - 04/2022
2	Chronic Renal Insufficiency 04/2023 - 04/2022
2	Fistula 01/2022 - 01/2019
1	Multicystic Dysplastic Kidney (Multicystic Kidney) 05/2024
1	Renal Insufficiency (Renal Failure) 05/2024
1	Hydronephrosis 04/2024
1	Hernia (Hernias) 01/2024
1	Ehrlich Tumor Carcinoma 06/2023
1	Ascites 06/2023
1	Malnutrition (Nutritional Deficiencies) 04/2023
1	Margins of Excision 01/2023
1	Stroke (Strokes) 01/2023
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 11/2022
1	Hypertrophy 04/2022
1	Chronic Disease (Chronic Diseases) 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Urinary Bladder Fistula (Vesical Fistula) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Anus Neoplasms (Anal Cancer) 01/2022
1	Intraoperative Complications 01/2021
1	Aggressive Fibromatosis (Desmoid) 11/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Cystitis 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Convalescence 01/2019
1	Ureteral Obstruction 01/2017
1	Aneurysm (Aneurysms) 05/2016
1	Infections 05/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016
1	Pancytopenia 05/2016
1	Rupture 05/2016
1	Seroma 10/2014
1	Pulmonary Embolism 07/2014

Drug/Important Bio-Agent (IBA)

3	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 04/2021
1	apalutamideIBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 06/2023
1	ethyl 4-methoxycinnamateIBA 06/2023
1	Cyclin D1IBA 06/2023
1	Keto AcidsIBA 04/2023
1	Amino Acids FDA Link 04/2023
1	Messenger RNA (mRNA)IBA 04/2023
1	UbiquitinIBA 04/2023
1	Ligases (Synthetase)IBA 04/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023
1	Axitinib (AG 013736)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Insulin ReceptorIBA 01/2023
1	4-azidosalicylic acid-phosphatidylserineIBA 11/2022
1	ImmunosorbentsIBA 04/2022
1	IpilimumabIBA 04/2022
1	EnzymesIBA 04/2022
1	Uremic ToxinsIBA 04/2022
1	NivolumabIBA 04/2022
1	Ursolic AcidIBA 04/2022
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Capsules (Microcapsules)IBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 02/2016
1	Polytetrafluoroethylene (Teflon)FDA Link 10/2014
1	Warfarin (Coumadin)FDA LinkGeneric 07/2014
1	Heparin (Liquaemin)FDA LinkGeneric 07/2014
1	AnticoagulantsIBA 07/2014

Therapy/Procedure

7	Cystectomy 03/2024 - 01/2017
4	Therapeutics 01/2023 - 07/2014
3	Urinary Diversion (Ileal Conduit) 04/2024 - 01/2019
3	Nephrectomy 01/2023 - 11/2020
3	Catheters 01/2023 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 10/2023
2	Brachytherapy 10/2023 - 03/2023
2	Length of Stay 01/2023 - 01/2019
2	Renal Dialysis (Hemodialysis) 09/2018 - 05/2016
1	Nephrotomy 05/2024
1	Castration 10/2023
1	Oral Administration 06/2023
1	Protein-Restricted Diet (Diet, Protein Restricted) 04/2023
1	Aftercare (After-Treatment) 03/2023
1	Urinary Catheters 01/2023
1	Sutures (Suture) 01/2023
1	Warm Ischemia 01/2023
1	Neoadjuvant Therapy 11/2022
1	Replantation 11/2022
1	Pelvic Exenteration 01/2022
1	Colostomy 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Radiotherapy 05/2021
1	Chemoradiotherapy 05/2021
1	Surgical Instruments (Clip) 01/2021
1	Herniorrhaphy 07/2019
1	Operative Time 01/2019
1	Conservative Treatment 01/2019
1	Splenectomy 05/2016
1	Nephroureterectomy 02/2016